| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC3332 |
| Trial ID | NCT05722171 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UTAA06 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute |
| Year | 2022 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-p002-015 |
| Cohort 1 | |||||||||
|
|||||||||